Auro-Sunitinib 12.5 mg (Sunitinib (Sunitinib Malate) CAPSULE) 12.5 MG

AURO-SUNITINIB 12.5 MG capsules are a pharmaceutical product containing Sunitinib Malate, used for various therapeutic purposes. This medication is manufactured by AURO PHARMA INC in Canada and is available in an oral capsule form.

Strength

12.5 MG

Manufacturer / TM Owner

AURO PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AURO-SUNITINIB 12.5 MG capsules are generally used in the treatment of certain types of cancer. Sunitinib Malate, the active ingredient, is often prescribed for its anti-cancer properties. The medication works by targeting specific proteins in the body to help slow or stop the growth of cancer cells. Patients should consult their healthcare provider to understand what Sunitinib is used for in their specific case.

Side Effects

Common effects of AURO-SUNITINIB 12.5 MG capsules may include fatigue, nausea, and diarrhea. Some users might experience skin discoloration or changes in hair color. It is important to note that individual responses to the medication can vary, and not everyone will experience these effects. Always discuss any concerns with a healthcare professional.

Precautions & Warnings

Handling AURO-SUNITINIB 12.5 MG capsules requires careful consideration of potential allergies to Sunitinib Malate or any other ingredients. Pregnant or breastfeeding individuals should exercise caution and consult a healthcare provider before use. Store the medication as directed and keep it out of reach of children.

Avoid Interactions

AURO-SUNITINIB 12.5 MG capsules may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. Alcohol consumption should be avoided as it may exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

AURO-SUNITINIB 12.5 MG capsules are typically used in the treatment of certain types of cancer, targeting specific proteins to help slow or stop the growth of cancer cells.

Store AURO-SUNITINIB 12.5 MG capsules in a cool, dry place, away from direct sunlight and out of reach of children.

Common side effects may include fatigue, nausea, diarrhea, and skin discoloration. Individual responses can vary.

AURO-SUNITINIB 12.5 MG may interact with certain medications, especially those metabolized by the liver's CYP3A4 enzyme. Always consult a healthcare provider before combining medications.

Pregnant individuals should consult a healthcare provider before using AURO-SUNITINIB 12.5 MG, as safety during pregnancy has not been established.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.